Evidence map›Paper›PMID 26365386›Full record

ArticleThe Journal of allergy and clinical immunology2016

A novel mutation in the POLE2 gene causing combined immunodeficiency.

Francesco Frugoni, Kerry Dobbs, Kerstin Felgentreff, Hasan Aldhekri, Bandar K Al Saud, Rand Arnaout, Afshan Ashraf Ali, Avinash Abhyankar, Fayhan Alroqi, Silvia Giliani and 6 more

Abstract readCase ReportsLetter
In one paragraph

Article in The Journal of allergy and clinical immunology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed.

  1. Trial
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Infections in DNA Repair Defects.Pathogens (Basel, Switzerland) · 2023
    Review
  12. Article
  13. Article
  14. Review
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Francesco FrugoniDivision of Immunology, Boston Children's Hospital, Boston, Mass.
Kerry DobbsDivision of Immunology, Boston Children's Hospital, Boston, Mass.
Kerstin FelgentreffDivision of Immunology, Boston Children's Hospital, Boston, Mass.
Hasan AldhekriDepartment of Pediatrics, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia.
Bandar K Al SaudDepartment of Pediatrics, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia.
Rand ArnaoutDepartment of Pediatrics, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia.
Afshan Ashraf AliDepartment of Pediatric Hematology/Oncology, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia.
Avinash AbhyankarNew York Genome Center, New York, NY.
Fayhan AlroqiDivision of Immunology, Boston Children's Hospital, Boston, Mass.
Silvia GilianiAngelo Nocivelli Institute of Molecular Medicine, University of Brescia, Brescia, Italy.
Mayra Martinez OjedaDepartment of Genetics, Boston Children's Hospital, Boston, Mass.
Erdyni TsitsikovDepartment of Laboratory Medicine, Boston Children's Hospital, Boston, Mass.
Sung-Yun PaiDivision of Pediatric Hematology-Oncology, Boston Children's Hospital, Boston, Mass.
Jean Laurent CasanovaSt Giles Laboratory of Human Genetics of Infectious Diseases, Rockefeller Branch, The Rockefeller University, New York, NY; Laboratory of Human Genetics of Infectious Diseases, Necker Branch, University Paris Descartes, Imagine Institute, Paris, France; Howard Hughes Medical Institute, New York, NY; Pediatric Hematology-Immunology Unit, Necker Hospital, Paris, France.
Luigi D NotarangeloDivision of Immunology, Boston Children's Hospital, Boston, Mass; Harvard Stem Cell Institute, Harvard University, Boston, Mass. Electronic address: luigi.notarangelo@childrens.harvard.edu.
John P ManisDepartment of Laboratory Medicine, Boston Children's Hospital, Boston, Mass; Department of Laboratory Medicine, Joint Program in Transfusion Medicine, Boston Children's Hospital, Boston, Mass; Department of Pathology, Harvard Medical School, Boston, Mass. Electronic address: manis@enders.tch.harvard.edu.

Funding

Modeling and correcting human SCID using patient-derived iPS cellsR01AI100887 · NIAID · BOSTON CHILDREN'S HOSPITAL · PI MANIS, JOHN P · 2012 to 2020
$4.5M
NIAID NIH HHS 5R01AI100887NIAID NIH HHS R01 AI100887NIAID NIH HHS R21AI87355
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

MutationChild, PreschoolDNA Mutational AnalysisDNA Polymerase IIFatal OutcomeHumansLymphocytesMaleSevere Combined ImmunodeficiencyDNA Polymerase II

Identifiers

PMID26365386
PMCPMC4747780

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.